McKesson, CD&R to Acquire Option Care Health for $5.8 Billion; Shares Jump 20%

McKesson Corp. and private equity firm Clayton Dubilier & Rice agreed to acquire Option Care Health Inc. for an enterprise value of approximately $5.8 billion, expanding into the medical infusion market, the companies said on October 6, 2026. CD&R will hold a majority stake in Option Care, which will continue under its existing management team. McKesson will invest about $1.4 billion for roughly a 49% interest. The offer represents a 37% premium to Option Care's closing price on Monday, October 5, 2026. Trading in the shares was halted before the New York open on Tuesday after surging more than 20% overnight following a Financial Times report on the talks. The transaction is expected to close in the first half of 2027.